Analyst Ratings

Upgrades, downgrades, and outlook changes from major analysts.

Coverage of analyst actions including upgrades, downgrades, initiations, and price-target changes. This category tracks how institutional research influences market perception, momentum shifts, and short-term price behavior.

Articles

3,520 total articles

Goldman Maintains $27 Price Target on Super Micro Computer After Q2 Beat; Concerns Over Margins Persist

Goldman Maintains $27 Price Target on Super Micro Computer After Q2 Beat; Concerns Over Margins Persist

Summary: Super Micro Computer (NASDAQ:SMCI) reported fiscal Q2 results that surpassed revenue and earnings expectations, drove management to lift fiscal 2026 revenue guidance, and highlighted sustained demand for AI infrastructure. Despite the top-line outperformance, gross margin compression, heavy revenue concentration in a single customer, and u…

DA Davidson Lifts APEI Price Target to $48, Citing End to Shutdown Overhang and Strong Operational Momentum

DA Davidson Lifts APEI Price Target to $48, Citing End to Shutdown Overhang and Strong Operational Momentum

DA Davidson raised its price objective on American Public Education (APEI) to $48 from $43 and kept a Buy rating, saying a recently passed funding bill removes a key overhang tied to the partial government shutdown. The firm pointed to the company’s military education leadership, profit gains at Rasmussen University, and AI-focused degree programs …

BofA Moves Omnicell to Buy, Sees Upside from Titan XT Rollout

BofA Moves Omnicell to Buy, Sees Upside from Titan XT Rollout

BofA Securities upgraded Omnicell (OMCL) from Neutral to Buy and increased its price target to $70 from $53, citing the upcoming launch of the Titan XT automated medication cabinet and the potential for an earnings revision cycle. The upgrade precedes Omnicell's earnings report scheduled for Thursday before market open and follows a string of analy…